This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionLast revisionBoth sides next revision | ||
home:publications:blaney_autoimmunity_2010 [06.14.2010] – paulalbert | home:publications:blaney_autoimmunity_2010 [06.21.2018] – [Presentation - Olmesartan medoxomil & treatment of autoimmune disease] sallieq | ||
---|---|---|---|
Line 5: | Line 5: | ||
{{ youtube> | {{ youtube> | ||
- | < | ||
**Type:** Conference presentation\\ | **Type:** Conference presentation\\ | ||
Line 100: | Line 99: | ||
Sixth, low dose, pulsed bacteriostatic antibiotics, | Sixth, low dose, pulsed bacteriostatic antibiotics, | ||
- | |||
- | |||
==== Slide 12 ==== | ==== Slide 12 ==== | ||
Finally, persistent infection is a likely cause of some autoimmune and chronic diseases that are associated with immune imbalance. The recognized capacity of bacteria to resist lysosomal degradation, | Finally, persistent infection is a likely cause of some autoimmune and chronic diseases that are associated with immune imbalance. The recognized capacity of bacteria to resist lysosomal degradation, | ||
+ | |||
+ | |||
+ | {{tag> | ||
===== Notes and comments ===== | ===== Notes and comments ===== | ||
Add this to heading after the PDF is completed: | Add this to heading after the PDF is completed: | ||
- | <html>< | + | < |
- | <a href=" | + | <a href=" |
- | </ | + | |
+ | </ | ||
===== References ===== | ===== References ===== |